Skip to main content
. 2016 Jan-Mar;28(1):19–26. doi: 10.5935/0103-507X.20160009

Table 1.

General characteristics of the patients in both groups

  Hypercapnic group Control group p-value
(N = 26) (N = 15)
Characteristic      
    Age (year) 48 ± 18 44 ± 14 0.364
    Gender M/F 15 (58)/11 (42) 5 (33)/10 (67) 0.239
    Weight (kg) 56 [50;68] 55 [46;64] 0.600
    Height (cm) 164 [158;170] 162 [154;168] 0.655
    APACHE II score * 22 [20;24] 18 [16;19] 0.571
    SAPS 3 score** 51 [33;53] 33 [26;43] 0.825
    SOFA 1st day 5 [3;7] 5 [3;9] 0.999
Comorbidities     0.455
    Hypertension 5 (19) 4 (27)  
    Diabetes 0 (0) 1 (7)  
    COPD 0 (0) 0 (0)  
    Chronic renal failure 0 (0) 0 (0)  
    Neoplasm 0 (0) 1 (7)  
Respiratory failure etiology      
    Pneumonia 22 (84) 13 (87) 1.000
    Asthma 2 (8) 0 (0) 0.524
    Septic syndromes 2 (8) 2 (13) 0.615
ICU support      
    Vasopressors 13 (50) 2 (13) 0.044
    Inotropics 11 (42) 6 (40) 0.854
Outcomes
    ICU LOS (days) 11 [6;17] 8 [7;10] 0.118
    Mortality 7 (27) 2 (13) 0.445

M/F - male/female; APACHE - acute physiology and chronic health disease classification system; SAPS - simplified acute physiological score; SOFA - sequential organ failure assessment; COPD - chronic obstructive pulmonary disease; ICU - intensive care unit; LOS - length of stay.

*

APACHE II score was retrieved from eleven patients;

**

SAPS 3 was retrieved from thirty patients. The results expressed in mean and standard deviation values.